| Bioactivity | LH708 is an orally active L-cystine crystallization inhibitor with an EC50 of 59.8 nM. LH708 can be used for Cystinuria research[1]. |
| CAS | 1616757-93-7 |
| Formula | C16H36Cl4N6O2S2 |
| Molar Mass | 550.44 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Longqin Hu, et al. 8-l-Cystinyl Bis(1,8-diazaspiro[4.5]decane) as an Orally Bioavailable l-Cystine Crystallization Inhibitor for Cystinuria, ACS Medicinal Chemistry Letters, Article ASAP |
LH708
CAS: 1616757-93-7 F: C16H36Cl4N6O2S2 W: 550.44
LH708 is an orally active L-cystine crystallization inhibitor with an EC50 of 59.8 nM. LH708 can be used for Cystinuria
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.